A 75-year-old gentleman with high-risk, non-metastatic prostate cancer has opted to undergo docetaxel therapy | Medibuddy
27th February 2025

A 75-year-old gentleman with high-risk, non-metastatic prostate cancer has opted to undergo docetaxel therapy

A 75-year-old gentleman with high-risk, non-metastatic prostate cancer has opted to undergo docetaxel therapy alongside goserelin (Zoladex). When counselling him on the docetaxel, what is the most important side he may experience?

Select the SINGLE most appropriate option from the list below. Select ONE option only.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.